Loading…
Loading…

Explore why U.S. public and private market valuations are diverging in 2026, and the key factors influencing multiples, investor expectations, liquidity, and pricing across both markets.
For much of the past several years, private market valuations in the US ran ahead of public market pricing, a pattern especially pronounced after the 2022 downturn. In 2026, that relationship will be reversed. Public equities now command higher valuations than private assets, marking a meaningful shift in how the two markets price risk and growth.
Public market multiples have continued expanding through 2026. The S&P 500's EV/EBITDA multiple rose from 16.7x in 2024 to 18.4x in 2026, reaching new highs in early June. Smaller-cap public companies followed suit, with the S&P 600's average multiple climbing to 12.4x, also a record.
Private market multiples moved the same direction, but far more modestly — median private EV/EBITDA rose from 11.5x in 2025 to just 11.9x in early 2026. For a private equity investor, a business once valued more richly outside public markets may now be worth more simply by being listed.
Why is the Gap Widening?
Interest rates remain higher for longer. Private valuations, particularly those built on discounted cash flow models, are highly sensitive to the discount rate applied to future cash flows, typically anchored to the risk-free rate. With rates staying elevated relative to pre-2022 norms, the mechanical effect is lower implied valuations for private, growth-dependent businesses even where performance hasn't changed.
Public markets are pricing cash flow; private markets are still pricing the future. Public equity investors increasingly reward demonstrated earnings and cash generation. Private markets, especially in growth-stage segments, continue pricing in future potential ,a bet that grows harder to justify as capital costs stay elevated.
Deal activity is concentrating at the extremes. Private equity exit activity through the first half of 2026 shows a stable deal count paired with sharply lower aggregate value, corporate acquisitions fell 63.5% quarter-over-quarter in value even as deal count held steady. This points to a repricing of deal size, not a retreat from the market: smaller transactions continue closing, while large, financing-dependent deals have become far harder to price.
The IPO window has reopened, but selectively. IPO value rose sharply in early 2026, driven by large listings in industrials, aerospace, and AI-driven platforms.The recovery is happening above the mid‑cap range. Smaller companies that want to go public still find a market that in practice stays closed to them.
What This Means for Valuation Practice?
This divergence carries direct implications for anyone valuing a business in 2026, whether for a transaction, a financing round, or financial reporting.
Comparable company analysis becomes considerably more sensitive to source selection in this environment. Using public comparables to value a private company — or the reverse — can now produce a materially different result than it would have two years ago, simply because the two markets are no longer moving in tandem.
Discounted cash flow valuations for private companies also carry more embedded sensitivity to rate assumptions than in recent years. A discount rate reasonable in 2021 or 2022 is unlikely to be defensible today, and valuers should expect greater scrutiny of rate assumptions in any report prepared during this period.
Sector selection matters more than usual too. Valuation gaps are not the same. In sectors like energy sectors like green energy and education have shown particularly wide gaps between public and private pricing, while others have converged more closely. A generic, sector-agnostic approach to comparables risks materially mispricing a business in either direction.
The reversal of the public-private valuation relationship in 2026 isn't a temporary anomaly — it reflects a genuine shift in how capital costs, growth expectations, and liquidity are being priced across both markets.For valuers, investors and those companies which are preparing for a transaction or a listing, it has become essential to understand where the comparable value comes from and why the two markets are no longer aligned if they are to produce a credible and defensible valuation.